🚀 VC round data is live in beta, check it out!
Active Biotech Valuation Multiples
Discover revenue and EBITDA valuation multiples for Active Biotech and similar public comparables like Biotechnology Assets, AcuCort, Alligator Bioscience, Aelis Farma and more.
Active Biotech Overview
About Active Biotech
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Founded
1998
HQ
Employees
7
Website
Sectors
Financials (LTM)
EV
$14M
Active Biotech Financials
Active Biotech reported last 12-month revenue of $698K and negative EBITDA of ($4M).
In the same LTM period, Active Biotech generated $698K in gross profit, ($4M) in EBITDA losses, and had net loss of ($4M).
Revenue (LTM)
Active Biotech P&L
In the most recent fiscal year, Active Biotech reported revenue of — and EBITDA of ($4M).
Active Biotech expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $698K | XXX | — | XXX | XXX | XXX |
| Gross Profit | $698K | XXX | — | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | — | XXX | XXX | XXX |
| EBITDA | ($4M) | XXX | ($4M) | XXX | XXX | XXX |
| EBITDA Margin | (581%) | XXX | — | XXX | XXX | XXX |
| EBIT Margin | (581%) | XXX | — | XXX | XXX | XXX |
| Net Profit | ($4M) | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | (507%) | XXX | — | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Active Biotech Stock Performance
Active Biotech has current market cap of $21M, and enterprise value of $14M.
Market Cap Evolution
Active Biotech's stock price is $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14M | $21M | 3.0% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialActive Biotech Valuation Multiples
Active Biotech trades at 20.5x EV/Revenue multiple, and (3.5x) EV/EBITDA.
EV / Revenue (LTM)
Active Biotech Financial Valuation Multiples
As of April 18, 2026, Active Biotech has market cap of $21M and EV of $14M.
Equity research analysts estimate Active Biotech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Active Biotech has a P/E ratio of (6.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $21M | XXX | $21M | XXX | XXX | XXX |
| EV (current) | $14M | XXX | $14M | XXX | XXX | XXX |
| EV/Revenue | 20.5x | XXX | — | XXX | XXX | XXX |
| EV/EBITDA | (3.5x) | XXX | (3.7x) | XXX | XXX | XXX |
| EV/EBIT | (3.5x) | XXX | (3.5x) | XXX | XXX | XXX |
| EV/Gross Profit | 20.5x | XXX | — | XXX | XXX | XXX |
| P/E | (6.0x) | XXX | (5.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Active Biotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Active Biotech Margins & Growth Rates
Active Biotech's revenue in the last 12 month grew by 254%.
Active Biotech's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.6M for the same period.
Active Biotech Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 254% | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | (581%) | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | (50%) | XXX | (6%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Active Biotech Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Active Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Biotechnology Assets | XXX | XXX | XXX | XXX | XXX | XXX |
| AcuCort | XXX | XXX | XXX | XXX | XXX | XXX |
| Alligator Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Aelis Farma | XXX | XXX | XXX | XXX | XXX | XXX |
| Diamyd Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Active Biotech M&A Activity
Active Biotech acquired XXX companies to date.
Last acquisition by Active Biotech was on XXXXXXXX, XXXXX. Active Biotech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Active Biotech
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialActive Biotech Investment Activity
Active Biotech invested in XXX companies to date.
Active Biotech made its latest investment on XXXXXXXX, XXXXX. Active Biotech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Active Biotech
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Active Biotech
| When was Active Biotech founded? | Active Biotech was founded in 1998. |
| Where is Active Biotech headquartered? | Active Biotech is headquartered in Sweden. |
| How many employees does Active Biotech have? | As of today, Active Biotech has over 7 employees. |
| Who is the CEO of Active Biotech? | Active Biotech's CEO is Helen Tuvesson. |
| Is Active Biotech publicly listed? | Yes, Active Biotech is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Active Biotech? | Active Biotech trades under ACTI ticker. |
| When did Active Biotech go public? | Active Biotech went public in 2000. |
| Who are competitors of Active Biotech? | Active Biotech main competitors are Biotechnology Assets, AcuCort, Alligator Bioscience, Aelis Farma. |
| What is the current market cap of Active Biotech? | Active Biotech's current market cap is $21M. |
| What is the current revenue of Active Biotech? | Active Biotech's last 12 months revenue is $698K. |
| What is the current revenue growth of Active Biotech? | Active Biotech revenue growth (NTM/LTM) is 254%. |
| What is the current EV/Revenue multiple of Active Biotech? | Current revenue multiple of Active Biotech is 20.5x. |
| Is Active Biotech profitable? | No, Active Biotech is not profitable. |
| What is the current EBITDA of Active Biotech? | Active Biotech has negative EBITDA and is not profitable. |
| What is Active Biotech's EBITDA margin? | Active Biotech's last 12 months EBITDA margin is (581%). |
| What is the current EV/EBITDA multiple of Active Biotech? | Current EBITDA multiple of Active Biotech is (3.5x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.